MAIN ARTICLE
A sponsorship relationship comes to an end
The RCN’s decision came ahead of a professional event on migraine and headache care at its London headquarters. Teva had been due to sponsor the program, but that support was cancelled. According to reports in The Guardian and Haaretz, the RCN also said it would no longer work with the company as a supplier. What might first appear to be a narrow sponsorship decision therefore became a broader statement about the standards an influential healthcare body expects from corporate partners.
Campaigners including Nurses for Palestine had urged the organization to sever links, citing what they characterize as Teva’s connections to the Israeli military. Those are claims made by advocacy groups, not proof that every alleged form of direct military support has been independently established. In explaining the decision, RCN council chair Carmel O’Boyle referred to an internal examination of activities that had drawn regulatory action and legal sanctions. That distinction matters: the organization framed its choice partly as an assessment of corporate conduct and professional values, not solely as a response to a company’s national identity.

















